Product NDC: | 42254-078 |
Proprietary Name: | Benzonatate |
Non Proprietary Name: | Benzonatate |
Active Ingredient(s): | 100 mg/1 & nbsp; Benzonatate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, LIQUID FILLED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42254-078 |
Labeler Name: | Rebel Distributors Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040682 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100113 |
Package NDC: | 42254-078-20 |
Package Description: | 20 CAPSULE, LIQUID FILLED in 1 BOTTLE (42254-078-20) |
NDC Code | 42254-078-20 |
Proprietary Name | Benzonatate |
Package Description | 20 CAPSULE, LIQUID FILLED in 1 BOTTLE (42254-078-20) |
Product NDC | 42254-078 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Benzonatate |
Dosage Form Name | CAPSULE, LIQUID FILLED |
Route Name | ORAL |
Start Marketing Date | 20100113 |
Marketing Category Name | ANDA |
Labeler Name | Rebel Distributors Corp |
Substance Name | BENZONATATE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC] |